Vertex Pharmaceuticals Incorporated (VRTX) Announces Appointment Of Jeffrey A. Chodakewitz, M.D., As Chief Medical Officer And Senior Vice President Of Global Medicines Development
1/9/2014 6:57:58 AM
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President. Dr. Chodakewitz has more than 20 years of experience leading global development organizations in the biopharmaceutical industry, including roles as Senior Vice President of late-stage global development and Vice President of early-stage development at Merck.
Help employers find you! Check out all the jobs and post your resume.
comments powered by